# PTC Therapeutics, Inc.: Form 8-K, filed Sep 28, 2023

- Company: [PTC Therapeutics, Inc.](/companies/ptct.md) (CIK 1070081)
- Form: 8-K
- Filed: 2023-09-28
- Accepted by EDGAR: Sep 28, 2023, 16:45 ET
- Period: 2023-09-28
- Accession: 0001070081-23-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070081/000107008123000053/tmb-20230928x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070081/000107008123000053/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070081/000107008123000053/tmb-20230928x8k.htm

Filed Sep 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001070081-23-000053. Last ingested by Listed: Nov 10, 2026, 17:24 ET. No prices; not investment advice.
